NCT05733715 2026-03-24Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell CarcinomaAbramson Cancer Center at Penn MedicinePhase EARLY_PHASE1 Recruiting30 enrolled
NCT05188118 2024-11-06Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell CarcinomaIcahn School of Medicine at Mount SinaiPhase EARLY_PHASE1 Recruiting20 enrolled